Analyzing hundreds of markers in a single tumor section [WEBINAR]

For more information visit: https://www.miltenyibiotec.com/applic... The tumor microenvironment (TME) is a heterogenous network of various cell types and structural elements. Ultra high content imaging can get you deep insights into the TME without compromising spatial information. In this webinar, we present how analyzing multiple markers combined with their spatial information is of a great advantage for deep TME phenotyping and biomarker discovery.
We introduce our unique MACSima™ Imaging Cyclic Staining (MICS) technology and validated MICS antibodies that enable imaging of hundreds of markers in a single tissue section. The imaging process is completely automated and the powerful MACS® iQ View Analysis Software was specifically developed to analyze the multidimensional datasets. Watch the webinar to get insights into highlighted applications of the MACSima Platform in TME research

Novel imaging technologies allow researchers to dive deep into limited sample material. Miltenyi Biotec’s ultra high content imaging workflow uses MICS (MACSima Imaging Cyclic Staining) technology on the MACSima Imaging Platform. It allows for automated fluorescence microscopic analysis of hundreds of markers on a single sample.Thus, it is perfectly suited to decipher complex questions in TME research, like target or biomarker identification, protein characterization, TIL phenotyping, or cancer classification.

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies enable solutions for cellular research, cell therapy, cell manufacturing, and imaging. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer, and clinical research areas like hematology, graft engineering, and apheresis. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 3,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.